Similar articles for PMID: 25805069

Year	Number of Results
1963	1
1965	1
1971	1
1977	1
1978	1
1979	1
1980	1
1981	1
1982	1
1984	1
1985	1
1987	2
1988	3
1989	1
1995	2
1997	3
1999	1
2000	2
2001	1
2002	2
2003	1
2004	2
2005	3
2006	1
2007	10
2008	4
2009	3
2010	8
2011	12
2012	5
2013	13
2014	15
2015	19
2016	21
2017	16
2018	15
2019	17
2020	13
2021	19
2022	16
2023	5
2024	0

1

In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.

Di X, Wang R, Liu B, Zhang X, Ni W, Wang J, Liang B, Cai Y, Liu Y. Di X, et al. J Antibiot (Tokyo). 2015 Sep;68(9):551-5. doi: 10.1038/ja.2015.27. Epub 2015 Mar 25. J Antibiot (Tokyo). 2015. PMID: 25805069

2

In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.

Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. Santimaleeworagun W, et al. Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):890-900. Southeast Asian J Trop Med Public Health. 2011. PMID: 22299471

3

Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates.

Kunakonvichaya B, Thirapanmethee K, Khuntayaporn P, Montakantikul P, Chomnawang MT. Kunakonvichaya B, et al. Int J Antimicrob Agents. 2015 May;45(5):556-7. doi: 10.1016/j.ijantimicag.2015.01.005. Epub 2015 Feb 10. Int J Antimicrob Agents. 2015. PMID: 25724628 No abstract available.

4

Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.

Mohanty S, Maurya V, Gaind R, Deb M. Mohanty S, et al. J Infect Dev Ctries. 2013 Nov 15;7(11):880-7. doi: 10.3855/jidc.2924. J Infect Dev Ctries. 2013. PMID: 24240048 Free article.

5

Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.

Lora-Tamayo J, Murillo O, Bergen PJ, Nation RL, Poudyal A, Luo X, Yu HY, Ariza J, Li J. Lora-Tamayo J, et al. J Antimicrob Chemother. 2014 Sep;69(9):2434-42. doi: 10.1093/jac/dku151. Epub 2014 May 15. J Antimicrob Chemother. 2014. PMID: 24833752

6

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.

Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Timurkaynak F, et al. Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7. Int J Antimicrob Agents. 2006. PMID: 16464562

7

Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.

Apisarnthanarak A, Mundy LM. Apisarnthanarak A, et al. Int J Antimicrob Agents. 2012 Mar;39(3):271-2. doi: 10.1016/j.ijantimicag.2011.11.012. Epub 2012 Jan 10. Int J Antimicrob Agents. 2012. PMID: 22236455 No abstract available.

8

Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.

Albiero J, Mazucheli J, Barros JPDR, Szczerepa MMDA, Nishiyama SAB, Carrara-Marroni FE, Sy S, Fidler M, Sy SKB, Tognim MCB. Albiero J, et al. Antimicrob Agents Chemother. 2019 May 24;63(6):e00126-19. doi: 10.1128/AAC.00126-19. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 30910903 Free PMC article.

9

Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation.

Asuphon O, Montakantikul P, Houngsaitong J, Kiratisin P, Sonthisombat P. Asuphon O, et al. Int J Infect Dis. 2016 Sep;50:23-9. doi: 10.1016/j.ijid.2016.06.017. Epub 2016 Jul 11. Int J Infect Dis. 2016. PMID: 27418581 Free article.

10

In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.

Walsh CC, McIntosh MP, Peleg AY, Kirkpatrick CM, Bergen PJ. Walsh CC, et al. J Antimicrob Chemother. 2015 Nov;70(11):3042-50. doi: 10.1093/jac/dkv221. Epub 2015 Jul 24. J Antimicrob Chemother. 2015. PMID: 26209311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

217 results

Results by year